Similarly, Franklin and colleagues [48] showed that in the postoperative setting, only stroma-derived circulating markers, such as collagen 4, endostatin, and osteopontin, were associated with shorter survival at high levels, whereas conventional tumor markers, such as CA19.9, CA125, and CEA, failed. The gene discussed is CEACAM5; the disease is neoplasm.